Acute and chronic effects of growth hormone on renal regulation of electrolyte and water homeostasis

Growth Hormone and IGF Research

Volumn 17, Issue 5, 2007, Pages 353-368

  Dimke, Henrik ^a   Flyvbjerg, Allan ^b   Frische, Sebastian ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Clinical Institute   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

AQP2; Growth hormone; IGF I; NKCC2; Sodium; Thick ascending limb

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; AQUAPORIN 2; ATRIAL NATRIURETIC FACTOR; BICARBONATE; CHLORIDE; ELECTROLYTE; GROWTH HORMONE; HORMONE RECEPTOR BLOCKING AGENT; HUMAN GROWTH HORMONE; INDOMETACIN; INSULIN; LITHIUM SALT; N(G) NITROARGININE METHYL ESTER; POTASSIUM; RECOMBINANT GROWTH HORMONE; RENIN; SODIUM; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SOMATOMEDIN C; VASOPRESSIN;

ACID BASE BALANCE; ACIDIFICATION; ACROMEGALY; ANTIDIURESIS; BICARBONATE BLOOD LEVEL; BLOOD PRESSURE MONITORING; CHLORIDE URINE LEVEL; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG WITHDRAWAL; ELECTROLYTE BALANCE; ELECTROLYTE URINE LEVEL; FAMILY HISTORY; FLUID RETENTION; GLOMERULUS FILTRATION RATE; GROWTH HORMONE DEFICIENCY; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; NONHUMAN; PLASMA RENIN ACTIVITY; POTASSIUM EXCRETION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIDE EFFECT; SODIUM EXCRETION; STREPTOZOCIN DIABETES; URINE VOLUME;

ANIMALS; DIABETES MELLITUS, TYPE 1; GLOMERULAR FILTRATION RATE; GROWTH HORMONE; HOMEOSTASIS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MODELS, BIOLOGICAL; WATER-ELECTROLYTE BALANCE;

EID: 34548355084     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.04.008     Document Type: Review

References (162)

1. Jaffe C.A., Pan W., Brown M.B., DeMott-Friberg R., and Barkan A.L. Regulation of GH secretion in acromegaly: reproducibility of daily GH profiles and attenuated negative feedback by IGF-I. J. Clin. Endocrinol. Metab. 86 (2001) 4364-4370
2. Jorgensen K.D. Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Demonstration of antinatriuretic/antidiuretic and barbital sleep effects of human growth hormone in rats. Acta Endocrinol. (Copenhagen) 114 (1987) 124-131
3. Satozawa N., Takezawa K., Miwa T., Takahashi S., Hayakawa M., and Ooka H. Differences in the effects of 20 K- and 22 K-hGH on water retention in rats. Growth Horm. IGF Res. 10 (2000) 187-192
4. Hansen T.K., Moller J., Thomsen K., Frandsen E., Dall R., Jorgensen J.O., and Christiansen J.S. Effects of growth hormone on renal tubular handling of sodium in healthy humans. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E1326-E1332
5. Ho K.Y., and Weissberger A.J. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism 39 (1990) 133-137
6. Ikkos D., Luft R., and Sjogren B. Body water and sodium in patients with acromegaly. J. Clin. Invest. 33 (1954) 989-994
7. Rosen T., Bosaeus I., Tolli J., Lindstedt G., and Bengtsson B.A. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin. Endocrinol. (Oxford) 38 (1993) 63-71
8. Moller J., Fisker S., Rosenfalck A.M., Frandsen E., Jorgensen J.O., Hilsted J., and Christiansen J.S. Long-term effects of growth hormone (GH) on body fluid distribution in GH deficient adults: a four months double blind placebo controlled trial. Eur. J. Endocrinol. 140 (1999) 11-16
9. Lieberman S.A., Bjorkengren A.G., and Hoffman A.R. Rheumatologic and skeletal changes in acromegaly. Endocrinol. Metab. Clin. North Am. 21 (1992) 615-631
10. Ayuk J., and Sheppard M.C. Growth hormone and its disorders. Postgrad. Med. J. 82 (2006) 24-30
11. Chihara K., Koledova E., Shimatsu A., Kato Y., Kohno H., Tanaka T., Teramoto A., Bates P.C., and Attanasio A.F. An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency. Eur. J. Endocrinol. 153 (2005) 57-65
12. Jorgensen J.O., Pedersen S.A., Thuesen L., Jorgensen J., Ingemann-Hansen T., Skakkebaek N.E., and Christiansen J.S. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1 (1989) 1221-1225
13. Moller J., Jorgensen J.O., Moller N., Hansen K.W., Pedersen E.B., and Christiansen J.S. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J. Clin. Endocrinol. Metab. 72 (1991) 768-772
14. Hayes F.J., Fiad T.M., and McKenna T.J. Activity of the renin-angiotensin-aldosterone axis is dependent on the occurrence of edema in growth hormone (GH)-deficient adults treated with GH. J. Clin. Endocrinol. Metab. 82 (1997) 322-323
15. Boger R.H., Skamira C., Bode-Boger S.M., Brabant G., von zur Muhlen A., and Frolich J.C. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J. Clin. Invest. 98 (1996) 2706-2713
16. Dimke H., Flyvbjerg A., Bourgeois S., Thomsen K., Frokiaer J., Houillier P., Nielsen S., and Frische S. Acute growth hormone administration induces antidiuretic and antinatriuretic effects and increases phosphorylation of NKCC2. Am. J. Physiol. Renal Physiol. 292 (2007) F723-F735
17. Thomsen M., Friis C., Sehested Hansen B., Johansen P., Eschen C., Nowak J., and Poulsen K. Studies on the renal kinetics of growth hormone (GH) and on the GH receptor and related effects in animals. J. Pediatr. Endocrinol. 7 (1994) 93-105
18. Mertani H.C., and Morel G. In situ gene expression of growth hormone (GH) receptor and GH binding protein in adult male rat tissues. Mol. Cell Endocrinol. 109 (1995) 47-61
19. Lobie P.E., Garcia-Aragon J., Wang B.S., Baumbach W.R., and Waters M.J. Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130 (1992) 3057-3065
20. Ballesteros M., Leung K.C., Ross R.J., Iismaa T.P., and Ho K.K. Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues. J. Clin. Endocrinol. Metab. 85 (2000) 2865-2871
21. Mercado M., DaVila N., McLeod J.F., and Baumann G. Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues. J. Clin. Endocrinol. Metab. 78 (1994) 731-735
22. Butler A.A., Funk B., Breier B.H., LeRoith D., Roberts Jr. C.T., and Gluckman P.D. Growth hormone (GH) status regulates GH receptor and GH binding protein mRNA in a tissue- and transcript-specific manner but has no effect on insulin-like growth factor-I receptor mRNA in the rat. Mol. Cell Endocrinol. 116 (1996) 181-189
23. Simard M., Manthos H., Giaid A., Lefebvre Y., and Goodyer C.G. Ontogeny of growth hormone receptors in human tissues: an immunohistochemical study. J. Clin. Endocrinol. Metab. 81 (1996) 3097-3102
24. Moller J., Moller N., Frandsen E., Wolthers T., Jorgensen J.O., and Christiansen J.S. Blockade of the renin-angiotensin-aldosterone system prevents growth hormone-induced fluid retention in humans. Am. J. Physiol. 272 (1997) E803-E808
25. Moller J., Jorgensen J.O., Frandsen E., Laursen T., and Christiansen J.S. Body fluids, circadian blood pressure and plasma renin during growth hormone administration: a placebo-controlled study with two growth hormone doses in healthy adults. Scand. J. Clin. Lab. Invest. 55 (1995) 663-669
26. Haffner D., Ritz E., Mehls O., Rosman J., Blum W., Heinrich U., and Hubinger A. Growth hormone induced rise in glomerular filtration rate is not obliterated by angiotensin-converting enzyme inhibitors. Nephron 55 (1990) 63-68
27. Bengtsson B.A., Eden S., Lonn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tolli J., Sjostrom L., and Isaksson O.G. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. 76 (1993) 309-317
28. Johannsson G., Sverrisdottir Y.B., Ellegard L., Lundberg P.A., and Herlitz H. GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis. J. Clin. Endocrinol. Metab. 87 (2002) 1743-1749
29. Binnerts A., Swart G.R., Wilson J.H., Hoogerbrugge N., Pols H.A., Birkenhager J.C., and Lamberts S.W. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin. Endocrinol. (Oxford) 37 (1992) 79-87
30. Barton J.S., Hindmarsh P.C., Preece M.A., and Brook C.G. Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone. Clin. Endocrinol. (Oxford) 38 (1993) 245-251
31. Wyse B., Waters M., and Sernia C. Stimulation of the renin-angiotensin system by growth hormone in Lewis dwarf rats. Am. J. Physiol. 265 (1993) E332-E339
32. Miller S.B., Rotwein P., Bortz J.D., Bechtel P.J., Hansen V.A., Rogers S.A., and Hammerman M.R. Renal expression of IGF I in hypersomatotropic states. Am. J. Physiol. 259 (1990) F251-F257
33. Jorgensen P.H., Bang C., Andreassen T.T., Flyvbjerg A., and Orskov H. Dose-response study of the effect of growth hormone on mechanical properties of skin graft wounds. J. Surg. Res. 58 (1995) 295-301
34. Hirschberg R., and Kopple J.D. The growth hormone-insulin-like growth factor I axis and renal glomerular function. J. Am. Soc. Nephrol. 2 (1992) 1417-1422
35. Sjogren K., Liu J.L., Blad K., Skrtic S., Vidal O., Wallenius V., LeRoith D., Tornell J., Isaksson O.G., Jansson J.O., et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. USA 96 (1999) 7088-7092
36. Frystyk J., Gronbaek H., Skjaerbaek C., and Flyvbjerg A. Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats. Am. J. Physiol. 269 (1995) E840-E845
37. Frystyk J., Skjaerbaek C., Dinesen B., and Orskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348 (1994) 185-191
38. Matejka G.L., Eriksson P.S., Carlsson B., and Jennische E. Distribution of IGF-I mRNA and IGF-I binding sites in the rat kidney. Histochemistry 97 (1992) 173-180
39. Bortz J.D., Rotwein P., DeVol D., Bechtel P.J., Hansen V.A., and Hammerman M.R. Focal expression of insulin-like growth factor I in rat kidney collecting duct. J. Cell Biol. 107 (1988) 811-819
40. Rogers S.A., Miller S.B., and Hammerman M.R. Growth hormone stimulates IGF I gene expression in isolated rat renal collecting duct. Am. J. Physiol. 259 (1990) F474-F479
41. Grone H.J., Neumann P., and Fuchs E. Localization and characterization of IGF-I receptors in fetal and adult human kidneys. Miner. Electrol. Metab. 18 (1992) 256-263
42. Chin E., Zhou J., and Bondy C. Anatomical relationships in the patterns of insulin-like growth factor (IGF)-I, IGF binding protein-1, and IGF-I receptor gene expression in the rat kidney. Endocrinology 130 (1992) 3237-3245
43. Chin E., Michels K., and Bondy C.A. Partition of insulin-like growth factor (IGF)-binding sites between the IGF-I and IGF-II receptors and IGF-binding proteins in the human kidney. J. Clin. Endocrinol. Metab. 78 (1994) 156-164
44. Bergenstal D.M., and Lipsett M.B. Metabolic effects of human growth hormone and growth hormone of other species in man. J. Clin. Endocrinol. Metab. 20 (1960) 1247-1435
45. Biglieri E., Watlington C., and Forsham P. Sodium retention with human growth hormone and its subfractions. J. Clin. Endocrinol. Metab. 21 (1961) 361-370
46. Parving H.H., Noer I., Mogensen C.E., and Svendsen P.A. Kidney function in normal man during short-term growth hormone infusion. Acta Endocrinol. (Copenhagen) 89 (1978) 796-800
47. Lockett M.F., and Nail B. A comparative study of the renal actions of growth and lactogenic hormones in rats. J. Physiol. 180 (1965) 147-156
48. Simone P.G., and Solomon S. Aldosterone and growth hormone: influence of diet and hypophysectomy on rat renal response. Proc. Soc. Exp. Biol. Med. 133 (1970) 786-789
49. Lockett M.F. A comparison of the direct renal actions of pituitary growth and lactogenic hormones. J. Physiol. 181 (1965) 192-199
50. Quigley R., and Baum M. Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J. Clin. Invest. 88 (1991) 368-374
51. Thomsen K. Lithium clearance: A new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 37 (1984) 217-223
52. Thomsen K., Shalmi M., and Olesen O.V. Effect of low dietary sodium and potassium on lithium clearance in rats. Miner. Electrol. Metab. 19 (1993) 91-98
53. Thomsen K., and Shirley D.G. The validity of lithium clearance as an index of sodium and water delivery from the proximal tubules. Nephron 77 (1997) 125-138
54. Stein Jr. J.D., Bennett L.L., Batts A.A., and Li C.H. Sodium, potassium and chloride retention produced by growth hormone in the absence of the adrenals. Am. J. Physiol. 171 (1952) 587-591
55. Hizuka N., Takano K., Asakawa K., Fukuda I., Sukegawa I., Shizume K., and Demura H. Single sc administration of insulin-like growth factor I (IGF-I) in normal men. Adv. Exp. Med. Biol. 293 (1991) 105-112
56. Hirschberg R., Brunori G., Kopple J.D., and Guler H.P. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 43 (1993) 387-397
57. Iioka Y., Tatsumi K., Sugito K., Moriya T., and Kuriyama T. Effects of insulin-like growth factor on nitrogen balance during hypoxic exposure. Eur. Respirat. J. 20 (2002) 293
58. Giordano M., and DeFronzo R.A. Acute effect of human recombinant insulin-like growth factor I on renal function in humans. Nephron 71 (1995) 10-15
59. Dorup I., and Clausen T. Insulin-like growth factor I stimulates active Na(+)-K+ transport in rat soleus muscle. Am. J. Physiol. 268 (1995) E849-E857
60. Snow M.H., Piercy D.A., Robson V., and Wilkinson R. An investigation into the pathogenesis of hypertension in acromegaly. Clin. Sci. Mol. Med. 53 (1977) 87-91
61. Herlitz H., Jonsson O., and Bengtsson B.A. Effect of recombinant human growth hormone on cellular sodium metabolism. Clin. Sci. (London) 86 (1994) 233-237
62. Moller J., Jensen M.B., Frandsen E., Moller N., Kissmeyer P., and Laurberg S. Growth hormone treatment improves body fluid distribution in patients undergoing elective abdominal surgery. Clin. Endocrinol. (Oxford) 49 (1998) 597-602
63. Kammerl M.C., Grimm D., Nabel C., Schweda F., Bach M., Fredersdorf S., Piehler H., Holmer S.R., Riegger G.A., Kromer E.P., et al. Effects of growth hormone on renal renin gene expression in normal rats and rats with myocardial infarction. Nephrol. Dial Transplant. 15 (2000) 786-790
64. Baumann U., Eisenhauer T., and Hartmann H. Increase of glomerular filtration rate and renal plasma flow by insulin-like growth factor-I during euglycaemic clamping in anaesthetized rats. Eur. J. Clin. Invest. 22 (1992) 204-209
65. Thompson J.L., Butterfield G.E., Gylfadottir U.K., Yesavage J., Marcus R., Hintz R.L., Pearman A., and Hoffman A.R. Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. J. Clin. Endocrinol. Metab. 83 (1998) 1477-1484
66. Ohtsuka H., Komiya I., Aizawa T., and Yamada T. Hypertension in acromegaly: Hereditary hypertensive factor produces hypertension by enhancing IGF-I production. Endocrinol. J. 42 (1995) 781-787
67. Jadresic A., Banks L.M., Child D.F., Diamant L., Doyle F.H., Fraser T.R., and Joplin G.F. The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q. J. Med. 51 (1982) 189-204
68. Pietrobelli D.J., Akopian M., Olivieri A.O., Renauld A., Garrido D., Artese R., and Feldstein C.A. Altered circadian blood pressure profile in patients with active acromegaly. Relationship with left ventricular mass and hormonal values. J. Hum. Hypertens. 15 (2001) 601-605
69. Ezzat S., Forster M.J., Berchtold P., Redelmeier D.A., Boerlin V., and Harris A.G. Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore) 73 (1994) 233-240
70. Kraatz C., Benker G., Weber F., Ludecke D., Hirche H., and Reinwein D. Acromegaly and hypertension: prevalence and relationship to the renin-angiotensin-aldosterone system. Klin. Wochenschr. 68 (1990) 583-587
71. Colao A., Baldelli R., Marzullo P., Ferretti E., Ferone D., Gargiulo P., Petretta M., Tamburrano G., Lombardi G., and Liuzzi A. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J. Clin. Endocrinol. Metab. 85 (2000) 193-199
72. Colao A., Ferone D., Marzullo P., Cappabianca P., Cirillo S., Boerlin V., Lancranjan I., and Lombardi G. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J. Clin. Endocrinol. Metab. 86 (2001) 2779-2786
73. Thuesen L., Christensen S.E., Weeke J., Orskov H., and Henningsen P. The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clin. Endocrinol. (Oxford) 30 (1989) 619-625
74. Lopez-Velasco R., Escobar-Morreale H.F., Vega B., Villa E., Sancho J.M., Moya-Mur J.L., and Garcia-Robles R. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension?. J. Clin. Endocrinol. Metab. 82 (1997) 1047-1053
75. Vitale G., Pivonello R., Auriemma R.S., Guerra E., Milone F., Savastano S., Lombardi G., and Colao A. Hypertension in acromegaly and in the normal population: prevalence and determinants. Clin. Endocrinol. (Oxford) 63 (2005) 470-476
76. Bohlooly Y.M., Carlson L., Olsson B., Gustafsson H., Andersson I.J., Tornell J., and Bergstrom G. Vascular function and blood pressure in GH transgenic mice. Endocrinology 142 (2001) 3317-3323
77. Hoffman D.M., Crampton L., Sernia C., Nguyen T.V., and Ho K.K. Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J. Clin. Endocrinol. Metab. 81 (1996) 1123-1128
78. Moller J., Frandsen E., Fisker S., Jorgensen J.O., and Christiansen J.S. Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clin. Endocrinol. (Oxford) 44 (1996) 533-539
79. Ahmad A.M., Hopkins M.T., Weston P.J., Fraser W.D., and Vora J.P. Effects of GH replacement on 24 h ambulatory blood pressure and its circadian rhythm in adult GH deficiency. Clin. Endocrinol. (Oxford) 56 (2002) 431-437
80. Maison P., Griffin S., Nicoue-Beglah M., Haddad N., Balkau B., and Chanson P. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. J. Clin. Endocrinol. Metab. 89 (2004) 2192-2199
81. Moller J., Jorgensen J.O., Marqversen J., Frandsen E., and Christiansen J.S. Insulin-like growth factor I administration induces fluid and sodium retention in healthy adults: possible involvement of renin and atrial natriuretic factor. Clin. Endocrinol. (Oxford) 52 (2000) 181-186
82. Haylor J., Singh I., and el Nahas A.M. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int. 39 (1991) 333-335
83. Hirschberg R., and Kopple J.D. Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J. Clin. Invest. 83 (1989) 326-330
84. Wu H.Y., Jeng Y.Y., Yue C.J., Chyu K.Y., Hsueh W.A., and Chan T.M. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. Diabetes 43 (1994) 1027-1032
85. Tsukahara H., Gordienko D.V., Tonshoff B., Gelato M.C., and Goligorsky M.S. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 45 (1994) 598-604
86. Thuesen L., Christiansen J.S., Sorensen K.E., Jorgensen J.O., Orskov H., and Henningsen P. Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. Dan. Med. Bull. 35 (1988) 193-196
87. Christiansen J.S., Gammelgaard J., Orskov H., Andersen A.R., Telmer S., and Parving H.H. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur. J. Clin. Invest. 11 (1981) 487-490
88. Whitney J.E., Bennett L.L., and Li C.H. Reduction of urinary sodium and potassium produced by hypophyseal growth hormone in normal female rats. Proc. Soc. Exp. Biol. Med. 79 (1952) 584-587
89. Tonshoff B., Nowack R., Kurilenko S., Blum W.F., Seyberth H.W., Mehls O., and Ritz E. Growth hormone-induced glomerular hyperfiltration is dependent on vasodilating prostanoids. Am. J. Kidney Dis. 21 (1993) 145-151
90. Karlberg B.E., and Ottosson A.M. Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol. (Copenhagen) 100 (1982) 581-587
91. Cain J.P., Williams G.H., and Dluhy R.G. Plasma renin activity and aldosterone secretion in patients with acromegaly. J. Clin. Endocrinol. Metab. 34 (1972) 73-81
92. Kopple J.D., Ding H., and Hirschberg R. Effects of recombinant human insulin-like growth factor 1 on renal handling of phosphorus, calcium, and sodium in normal humans. Am. J. Kidney Dis. 26 (1995) 818-824
93. Takano K., Hizuka N., Shizume K., Asakawa K., Fukuda I., and Demura H. Repeated sc administration of recombinant human insulin-like growth factor I (IGF-I) to human subjects for 7 days. Growth Regulat. 1 (1991) 23-28
94. Asplin C.M., Faria A.C., Carlsen E.C., Vaccaro V.A., Barr R.E., Iranmanesh A., Lee M.M., Veldhuis J.D., and Evans W.S. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 69 (1989) 239-245
95. Nieves-Rivera F., Rogol A.D., Veldhuis J.D., Branscom D.K., Martha Jr. P.M., and Clarke W.L. Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 77 (1993) 638-643
96. Bereket A., Lang C.H., and Wilson T.A. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm. Metab. Res. 31 (1999) 172-181
97. Hansen A.P. Abnormal serum growth hormone response to exercise in juvenile diabetics. J. Clin. Invest. 49 (1970) 1467-1478
98. Johansen K., and Hansen A.P. Diurnal serum growth hormone levels in poorly and well-controlled juvenile diabetics. Diabetes 20 (1971) 239-245
99. Johansen P.B., Segev Y., Landau D., Phillip M., and Flyvbjerg A. Growth hormone (GH) hypersecretion and GH receptor resistance in streptozotocin diabetic mice in response to a GH secretagogue. Exp. Diabesity Res. 4 (2003) 73-81
100. Lurbe E., Redon J., Kesani A., Pascual J.M., Tacons J., Alvarez V., and Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl. J. Med. 347 (2002) 797-805
101. Flyvbjerg A., Bennett W.F., Rasch R., Kopchick J.J., and Scarlett J.A. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes 48 (1999) 377-382
102. Falkheden T., and Wickbom I. Renal function and kidney size following hypophysectomy in man. Acta Endocrinol. (Copenhagen) 48 (1965) 348-354
103. Hirschberg R. Effects of growth hormone and IGF-I on glomerular ultrafiltration in growth hormone-deficient rats. Regul. Pept. 48 (1993) 241-250
104. Miller S.B., Hansen V.A., and Hammerman M.R. Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass. Am. J. Physiol. 259 (1990) F747-F751
105. Hirschberg R., Rabb H., Bergamo R., and Kopple J.D. The delayed effect of growth hormone on renal function in humans. Kidney Int. 35 (1989) 865-870
106. Guler H.P., Schmid C., Zapf J., and Froesch E.R. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc. Natl. Acad. Sci. USA 86 (1989) 2868-2872
107. Caverzasio J., Montessuit C., and Bonjour J.P. Stimulatory effect of insulin-like growth factor-1 on renal Pi transport and plasma 1,25-dihydroxyvitamin D3. Endocrinology 127 (1990) 453-459
108. Hirschberg R., Kopple J.D., Blantz R.C., and Tucker B.J. Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J. Clin. Invest. 87 (1991) 1200-1206
109. Nielsen S., Frokiaer J., Marples D., Kwon T.H., Agre P., and Knepper M.A. Aquaporins in the kidney: from molecules to medicine. Physiol. Rev. 82 (2002) 205-244
110. Orson M., Baum M., Berry C., and Rector F. Brenner & Rector's the kidney. In: Brenner B. (Ed). Renal Transport of Glucose, Amino Acids, Sodium, Chloride and Water (2004), Saunders, Philadelphia 413-453 (Chapter 9)
111. Knepper M., and Gamba G. Brenner & Rector's the kidney. In: Brenner B. (Ed). Brenner & Rector's the kidney (2004), Saunders, Philadelphia 599-636 (Chapter 14)
112. Ecelbarger C.A., Terris J., Hoyer J.R., Nielsen S., Wade J.B., and Knepper M.A. Localization and regulation of the rat renal Na(+)-K(+)-2Cl(-) cotransporter, BSC-1. Am. J. Physiol. 271 (1996) F619-F628
113. Nielsen S., Maunsbach A.B., Ecelbarger C.A., and Knepper M.A. Ultrastructural localization of Na-K-2Cl cotransporter in thick ascending limb and macula densa of rat kidney. Am. J. Physiol. 275 (1998) F885-F893
114. + cotransport in macula densa cells. Am. J. Physiol. 258 (1990) F1466-F1469
115. De Rouffignac C. Multihormonal regulation of nephron epithelia: achieved through combinational mode?. Am. J. Physiol. 269 (1995) R739-R748
116. Gimenez I., and Forbush B. Regulatory Phosphorylation Sites in the N-terminus of the renal Na-K-Cl cotransporter (NKCC2). Am. J. Physiol. Renal Physiol. 289 (2005) F1341-F1345
117. Gimenez I., and Forbush B. Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein. J. Biol. Chem. 278 (2003) 26946-26951
118. Wittner M., di Stefano A., Wangemann P., Nitschke R., Greger R., Bailly C., Amiel C., Roinel N., and de Rouffignac C. Differential effects of ADH on sodium, chloride, potassium, calcium and magnesium transport in cortical and medullary thick ascending limbs of mouse nephron. Pflugers. Arch. 412 (1988) 516-523
119. Malnic G., Bailey M., and Giebisch G. Brenner & Rector's the kidney. In: Brenner B. (Ed). Control of Renal Potassium Excretion (2004), Saunders, Philadelphia (Chapter 10). pp. 453-497
120. Piechotta K., Lu J., and Delpire E. Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1). J. Biol. Chem. 277 (2002) 50812-50819
121. Ushiro H., Tsutsumi T., Suzuki K., Kayahara T., and Nakano K. Molecular cloning and characterization of a novel Ste20-related protein kinase enriched in neurons and transporting epithelia. Arch. Biochem. Biophys. 355 (1998) 233-240
122. Tamari M., Daigo Y., and Nakamura Y. Isolation and characterization of a novel serine threonine kinase gene on chromosome 3p22-21.3. J. Hum. Genet. 44 (1999) 116-120
123. - cotransporter in HeLa cells. Proc. Natl. Acad. Sci. USA 103 (2006) 10883-10888
124. Moriguchi T., Urushiyama S., Hisamoto N., Iemura S.-I., Uchida S., Natsume T., Matsumoto K., and Shibuya H. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J. Biol. Chem. 280 (2005) 42685-42693
125. - cotransporters required for normal blood pressure homeostasis. PNAS 102 (2005) 16777-16782
126. Chobanian M.C., Julin C.M., Molteni K.H., and Brazy P.C. Growth hormone regulates ammoniagenesis in canine renal proximal tubule segments. Am. J. Physiol. Renal Physiol. 262 (1992) F878-F884
127. Ng L.L., and Evans D.J. Leucocyte sodium transport in acromegaly. Clin. Endocrinol. (Oxford) 26 (1987) 471-480
128. Shimomura Y., Lee M., Oku J., Bray G.A., and Glick Z. Sodium potassium dependent ATPase in hypophysectomized rats: response to growth hormone, triiodothyronine, and cortisone. Metabolism 31 (1982) 213-216
129. Everts M.E., Dorup I., Flyvbjerg A., Marshall S.M., and Jorgensen K.D. Na(+)-K+ pump in rat muscle: effects of hypophysectomy, growth hormone, and thyroid hormone. Am. J. Physiol. 259 (1990) E278-E283
130. Salomon F., Cuneo R.C., Hesp R., Morris J.F., Poston L., and Sonksen P.H. Basal metabolic rate in adults with growth hormone deficiency and in patients with acromegaly: relationship with lean body mass, plasma insulin level and leucocyte sodium pump activity. Clin. Sci. (London) 83 (1992) 325-330
131. Dorup I., Flyvbjerg A., Everts M.E., and Orskov H. Effects of growth hormone on growth and muscle Na(+)-K+ pump concentration in K(+)-deficient rats. Am. J. Physiol. 262 (1992) E511-E517
132. Feraille E., Marsy S., Cheval L., Barlet-Bas C., Khadouri C., Favre H., and Doucet A. Sites of antinatriuretic action of insulin along rat nephron. Am. J. Physiol. Renal Physiol. 263 (1992) F175-F179
133. Feraille E., Rousselot M., Rajerison R., and Favre H. Effect of insulin on Na+, K(+)-ATPase in rat collecting duct. J. Physiol. 488 Pt 1 (1995) 171-180
134. +)-ATPase by insulin/insulin-like growth factor-I in cultured rat astrocytes. Arch. Biochem. Biophys. 307 (1993) 175-182
135. Standley P.R., Zhang F., Zayas R.M., Muniyappa R., Walsh M.F., Cragoe E., and Sowers J.R. IGF-I regulation of Na(+)-K(+)-ATPase in rat arterial smooth muscle. Am. J. Physiol. 273 (1997) E113-E121
136. Glaser N.S., Shirali A.C., Styne D.M., and Jones K.L. Acid-base homeostasis in children with growth hormone deficiency. Pediatrics 102 (1998) 1407-1414
137. Sicuro A., Mahlbacher K., Hulter H.N., and Krapf R. Effect of growth hormone on renal and systemic acid-base homeostasis in humans. Am. J. Physiol. Renal Physiol. 274 (1998) F650-F657
138. Welbourne T.C., and Cronin M.J. Growth hormone accelerates tubular acid secretion. Am. J. Physiol. 260 (1991) R1036-R1042
139. (-)-cotransporter. J. Membr. Biol. 94 (1986) 279-284
140. Honeyman T.W., Goodman H.M., and Fray J.C. The effects of growth hormone on blood pressure and renin secretion in hypophysectomized rats. Endocrinology 112 (1983) 1613-1617
141. Epstein S., Le Roith D., and Rabkin R. The effect of different preparations of human growth hormone on plasma renin activity in normal males. J. Clin. Endocrinol. Metab. 42 (1976) 390-392
142. Huang W.C. Renal hemodynamic and tubular effects of angiotensins II and III. Chin. J. Physiol. 34 (1991) 121-138
143. Mitchell K.D., and Navar L.G. Influence of intrarenally generated angiotensin II on renal hemodynamics and tubular reabsorption. Ren. Physiol. Biochem. 14 (1991) 155-163
144. Candido R., Burrell L., Jandeleit-Dahm K., and Cooper M. Brenner & Rector's the kidney. In: Brenner B. (Ed). Vasoactive Peptides and the Kidney (2004), Saunders, Philadelphia 663-726 (Chapter 16)
145. Venning E.H., Dyrenfurth I., Giroud C.J., and Beck J.C. Effect of growth hormone on aldosterone excretion. Metabolism 5 (1956) 697-702
146. Chipman J.J., Zerwekh J., Nicar M., Marks J., and Pak C.Y. Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption. J. Clin. Endocrinol. Metab. 51 (1980) 321-324
147. Gertner J.M., Horst R.L., Broadus A.E., Rasmussen H., and Genel M. Parathyroid function and vitamin D metabolism during human growth hormone replacement. J. Clin. Endocrinol. Metab. 49 (1979) 185-188
148. Christensen B.M., Zelenina M., Aperia A., and Nielsen S. Localization and regulation of PKA-phosphorylated AQP2 in response to V(2)-receptor agonist/antagonist treatment. Am. J. Physiol. Renal Physiol. 278 (2000) F29-F42
149. Fushimi K., Sasaki S., and Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J. Biol. Chem. 272 (1997) 14800-14804
150. Nishimoto G., Zelenina M., Li D., Yasui M., Aperia A., Nielsen S., and Nairn A.C. Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue. Am. J. Physiol. 276 (1999) F254-F259
151. Zelenina M., Christensen B.M., Palmer J., Nairn A.C., Nielsen S., and Aperia A. Prostaglandin E(2) interaction with AVP: effects on AQP2 phosphorylation and distribution. Am. J. Physiol. Renal Physiol. 278 (2000) F388-F394
152. Katsura T., Gustafson C.E., Ausiello D.A., and Brown D. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am. J. Physiol. 272 (1997) F817-F822
153. Nielsen S., Chou C.L., Marples D., Christensen E.I., Kishore B.K., and Knepper M.A. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc. Natl. Acad. Sci. USA 92 (1995) 1013-1017
154. Marcus R., Butterfield G., Holloway L., Gilliland L., Baylink D.J., Hintz R.L., and Sherman B.M. Effects of short term administration of recombinant human growth hormone to elderly people. J. Clin. Endocrinol. Metab. 70 (1990) 519-527
155. Ito O., Kondo Y., Takahashi N., Omata K., and Abe K. Role of calcium in insulin-stimulated NaCl transport in medullary thick ascending limb. Am. J. Physiol. 269 (1995) F236-F241
156. Skjaerbaek C., Frystyk J., Kaal A., Laursen T., Moller J., Weeke J., Jorgensen J.O., Sandahl Christiansen J., and Orskov H. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency. Clin. Endocrinol. (Oxford) 52 (2000) 25-33
157. Glafkides C.M., and Bennett L.L. Reduction of urinary sodium and potassium of diabetic rats produced by hypophyseal growth hormone. Proc. Soc. Exp. Biol. Med. 77 (1951) 524-526
158. Ghanaat F., and Tayek J.A. Growth hormone administration increases glucose production by preventing the expected decrease in glycogenolysis seen with fasting in healthy volunteers. Metabolism 54 (2005) 604-609
159. Bank N., and Aynedjian H.S. Progressive increases in luminal glucose stimulate proximal sodium absorption in normal and diabetic rats. J. Clin. Invest. 86 (1990) 309-316
160. de Bold A.J., Borenstein H.B., Veress A.T., and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28 (1981) 89-94
161. Wang W., Li C., Nejsum L.N., Li H., Kim S.W., Kwon T.H., Jonassen T.E., Knepper M.A., Thomsen K., Frokiaer J., et al. Euvolumic rats: roles of AQP2 and ENaC trafficking. Am. J. Physiol. Renal Physiol. 290 (2006) F530-F541
162. Deray G., Chanson P., Maistre G., Warnet A., Eurin J., Barthelemy C., Masson F., Martinez F., Lubetzki J., Legrand J.C., et al. Atrial natriuretic factor in patients with acromegaly. Eur. J. Clin. Pharmacol. 38 (1990) 409-413